Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

James ND, de Bono JS, Spears MR, Clarke NW, Mason MD, Dearnaley DP, Ritchie AWS, Amos CL, Gilson C, Jones RJ, Matheson D, Millman R, Attard G, Chowdhury S, Cross WR, Gillessen S, Parker CC, Russell JM, Berthold DR, Brawley C, Adab F, Aung S, Birtle AJ, Bowen J, Brock S, Chakraborti P, Ferguson C, Gale J, Gray E, Hingorani M, Hoskin PJ, Lester JF, Malik ZI, McKinna F, McPhail N, Money-Kyrle J, O'Sullivan J, Parikh O, Protheroe A, Robinson A, Srihari NN, Thomas C, Wagstaff J, Wylie J, Zarkar A, Parmar MKB, Sydes MR; STAMPEDE Investigators.

N Engl J Med. 2017 Jul 27;377(4):338-351. doi: 10.1056/NEJMoa1702900. Epub 2017 Jun 3.

2.

Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.

Teagle AR, Gilbert DC, Jones JR, Burkill GJ, McKinna F, Dizdarevic S.

Nucl Med Commun. 2016 Oct;37(10):1038-45. doi: 10.1097/MNM.0000000000000560.

PMID:
27341410
3.

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators.

Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21.

4.

The elephant in the room?

Marien B, McKinna F.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):654-6. doi: 10.1016/j.clon.2012.07.014. Epub 2012 Aug 17. No abstract available.

PMID:
22906545
5.

Rising carcinoembryonic antigen during follow-up for colonic carcinoma--an unusual presentation of medullary carcinoma of the thyroid.

Breeze J, McKinna F, Howlett DC.

Clin Oncol (R Coll Radiol). 2008 Jun;20(5):382. doi: 10.1016/j.clon.2008.02.009. Epub 2008 Apr 18. No abstract available.

PMID:
18374551
6.

Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy.

Pritchard J, Anand P, Broome J, Davis C, Gothard L, Hall E, Maher J, McKinna F, Millington J, Misra VP, Pitkin A, Yarnold JR.

Radiother Oncol. 2001 Mar;58(3):279-86.

PMID:
11230889
7.

Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer.

McKinna F, Gothard L, Ashley S, Ebbs S, Yarnold J.

Radiother Oncol. 1999 Sep;52(3):219-23.

PMID:
10580867
8.

Lymphatic relapse in women with early breast cancer: a difficult management problem.

McKinna F, Gothard L, Ashley S, Ebbs SR, Yarnold JR.

Eur J Cancer. 1999 Jul;35(7):1065-9.

PMID:
10533449

Supplemental Content

Loading ...
Support Center